Abstract
Get full access to this article
View all access options for this article.
References
1.
Polack
FP
Thomas
SJ
Kitchin
N
, et al . Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine . N Engl J Med 2020 ; 383 (27 ): 2603 –2615 .
2.
Baden
LR
El Sahly
HM
Essink
B
, et al . Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine . N Engl J Med 2021 ; 384 (5 ): 403 –416 .
3.
Blumenthal
KG
Freeman
EE
Saff
RR
, et al . Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2 . N Engl J Med 2021 ; 384 (13 ): 1273 –1277 .
4.
Achiron
A
Mandel
M
Dreyer-Alster
S
, et al . Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies . Ther Adv Neurol Diso 2021 ; 14 : 17562864211012835 .